Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Atherosclerosis|August 21, 2013
Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperationGiuseppe De Luca, Monica Verdoia, Maurits T Dirksen, et al.
Lancet (London, England)|March 18, 2014
Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trialMichael Maeng, Hans Henrik Tilsted, Lisette Okkels Jensen, et al.
Circulation|August 30, 2008
Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trialHenning Kelbaek, Leif Thuesen, Steffen Helqvist, et al.
Archives of Internal Medicine|April 25, 2012
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trialsGiuseppe De Luca, Maurits T Dirksen, Christian Spaulding, et al.
JACC. Cardiovascular Interventions|November 20, 2010
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stentsJosep Gomez-Lara, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|July 23, 2011
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-upJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
JACC. Cardiovascular Interventions|January 23, 2017
Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI TrialBent Raungaard, Evald H Christiansen, Hans Erik Bøtker, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO studyYves-Laurent Bayard, Heyder Omran, Petr Neuzil, et al.
JACC. Cardiovascular Interventions|August 25, 2012
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stentsMichael Maeng, Hans-Henrik Tilsted, Lisette Okkels Jensen, et al.
American Heart Journal|August 2, 2017
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patientsTullio Palmerini, Patrick Serruys, Arie Pieter Kappetein, et al.
Pageof 23